Efficacy and Safety of Tirofiban Plus Recombinant Tissue Plasminogen Activator Versus Recombinant Tissue Plasminogen Activator Alone in Acute Ischemic Stroke Patients: a Meta-Analysis
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES（2025）
Key words
Acute ischemic stroke,Tirofiban,Recombinant tissue plasminogen activator,Efficacy,Safety
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined